United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ] for the management of the signs and symptoms of ra [see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] for the management of the signs and symptoms of as [see clinical studies (14.4) ] for the management of acute pain in adults [see clinical studies (14.5) ] for the management of primary dysmenorrhea [see clinical studies (14.5) ] celecoxib capsules are contraindicated in the following patients: pregnancy category c. pregnancy category d from 30 weeks of gestation onward. risk summary use of nsaids, including celecoxib capsules, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including celecoxib capsules, in pregnant women starting at 30 weeks of gestation. there are no adequate and well-controlled studies of cele

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ] for the management of the signs and symptoms of ra [see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] for the management of the signs and symptoms of as [see clinical studies (14.4) ] for the management of acute pain in adults [see clinical studies (14.5) ] for the management of primary dysmenorrhea [see clinical studies (14.5) ] • celecoxib capsules are contraindicated in the following patients: known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9) ]. • history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids, have been reported in such patients [see warnings and precautions (5.7, 5.8) ]

United States - English - NLM (National Library of Medicine)

redpharm drug, inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - celecoxib capsules are indicated 1.1 osteoarthritis (oa) for the management of the signs and symptoms of oa [see clinical studies (14.1)]. 1.2 rheumatoid arthritis (ra) for the management of the signs and symptoms of ra [see clinical studies (14.2)]. 1.3 juvenile rheumatoid arthritis (jra) for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)]. 1.4 ankylosing spondylitis (as) for the management of the signs and symptoms of as [see clinical studies (14.4)]. 1.5 acute pain (ap) for the management of acute pain in adults [see clinical studies (14.5)]. 1.6 primary dysmenorrhea (pd) for the management of primary dysmenorrhea [see clinical studies (14.5)]. celecoxib capsules are contraindicated in the following patients: known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9) ]. history of asthma, urticaria, or other allergic-type reactions

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 100 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ] for the management of the signs and symptoms of ra [see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] for the management of the signs and symptoms of as [see clinical studies (14.4) ] for the management of acute pain in adults [see clinical studies (14.5) ] for the management of primary dysmenorrhea [see clinical studies (14.5) ] celecoxib capsules are contraindicated in the following patients: pregnancy category c. pregnancy category d from 30 weeks of gestation onward. risk summary use of nsaids, including celecoxib capsules, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including celecoxib capsules, in pregnant women starting at 30 weeks of gestation. there are no adequate and well-controlled studies of cele

United States - English - NLM (National Library of Medicine)

direct rx - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 100 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see warnings and precautions (5)] 1.1 osteoarthritis (oa) celecoxib is indicated for relief of the signs and symptoms of oa [see clinical studies (14.1)] 1.2 rheumatoid arthritis (ra) celecoxib is indicated for relief of the signs and symptoms of ra [see clinical studies (14.2)] 1.3 juvenile rheumatoid arthritis (jra) celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] 1.4 ankylosing spondylitis (as) celecoxib is indicated for the relief of signs and symptoms of as [see clinical studies (14.4)] 1.5 acute pain (ap) celecoxib is indicated for the management of ap in adults [see clinical studies (14.5)] 1.6 primary dysmenorrhea (pd) celecoxib is indicated for the treatment of pd [see clinical studies (14.5)]

United States - English - NLM (National Library of Medicine)

jubilant cadista pharmaceuticals inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 50 mg - celecoxib capsules are indicated. for the management of the signs and symptoms of oa [see clinical studies (14.1)] for the management of the signs and symptoms of ra [see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] for the management of the signs and symptoms of as [see clinical studies (14.4) ] for the management of acute pain in adults [see clinical studies (14.5) ] for the management of primary dysmenorrhea [see clinical studies (14.5)]   celecoxib is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9)]. known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9)]. - history of asthma, urticaria, or other allergic-type reactions after

United States - English - NLM (National Library of Medicine)

blenheim pharmacal, inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [ see warnings and precautions (5) ] celecoxib is indicated for relief of the signs and symptoms of oa [ see clinical studies (14.1) ] celecoxib is indicated for relief of the signs and symptoms of ra [ see clinical studies (14.2) ] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [ see clinical studies (14.3) ] celecoxib is indicated for the relief of signs and symptoms of as [ see clinical studies (14.4) ] celecoxib is indicated for the management of ap in adults [ see clinical studies (14.5) ] celecoxib is indicated for the treatment of pd [

United States - English - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 100 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see warnings and precautions (5) ] celecoxib is indicated for relief of the signs and symptoms of oa [see clinical studies (14.1) ] celecoxib is indicated for relief of the signs and symptoms of ra [see clinical studies (14.2) ] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] celecoxib is indicated for the relief of signs and symptoms of as [see clinical studies (14.4) ] celecoxib is indicated for the management of ap in adults [see clinical studies (14.5) ] celecoxib is indicated for the treatment of pd [see clinical studies (14.5) ] celecoxib is contraindicated: - in patients with known hypersensitivity to celecoxib, aspirin, or other nsaids. - in patients who have demonstrated allergic-type react

United States - English - NLM (National Library of Medicine)

medsource pharmaceuticals - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [ see warnings and precautions (5) ] celecoxib is indicated for relief of the signs and symptoms of oa [ see clinical studies (14.1) ] celecoxib is indicated for relief of the signs and symptoms of ra [ see clinical studies (14.2) ] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [ see clinical studies (14.3) ] celecoxib is indicated for the relief of signs and symptoms of as [ see clinical studies (14.4) ] celecoxib is indicated for the management of ap in adults [ see clinical studies (14.5) ] celecoxib is indicated for the treatment of pd [

United States - English - NLM (National Library of Medicine)

blenheim pharmcal, inc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [ see warnings and precautions (5) ] celecoxib is indicated for relief of the signs and symptoms of oa [ see clinical studies (14.1) ] celecoxib is indicated for relief of the signs and symptoms of ra [ see clinical studies (14.2) ] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [ see clinical studies (14.3) ] celecoxib is indicated for the relief of signs and symptoms of as [ see clinical studies (14.4) ] celecoxib is indicated for the management of ap in adults [ see clinical studies (14.5) ] celecoxib is indicated for the treatment of pd [